Accretion Pharmaceuticals IPO

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products. The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup). The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems. The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat. The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East. Product Portfolio and Services Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines. Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments. External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments. Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health. As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll. Competitive Strength: Experienced Promoters and Management Team. Long-standing relationship with clients and suppliers. Focus on providing quality products. Management has built a supply chain and customer relations, creating goodwill and trust.

The Company Accretion Pharmaceuticals IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (in Millions) 1 Capital expenditure towards purchase of new equipment/ machineries, etc. 26.97 2 Capital expenditure towards upgradation of existing manufacturing facility 46.56 3 Repayment/prepayme nt of certain borrowings availed by the Company 9.92 4 Funding working capital requirements 146.80 5 General Corporate Purpose

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App